The second edition of Bormioli Pharma's Sustainability Report reaffirmed the commitment to environmental and social responsibility, protecting the wellbeing of people and the environment, in line with its mission to 'Make health a positive practice, accessible to everyone, kind to the planet'. The report includes several new items, involving both the objectives to be achieved and the governance system through which the company intends to achieve an increasingly sustainable development path.

Of the main targets, the 30% CO2 reduction by 2030 (compared to 2021) has been confirmed, and new ones have been introduced, such as the commitment to carry out an initial life cycle analysis on a glass product by the end of this year and to complete the assessment of 'Scope 3' emissions. The '50in5' target of increasing the share of sustainable raw materials in production processes has also been confirmed. The goal of reducing water consumption has been made more challenging and raised from -30% to -41%.

A further new factor concerns the strengthening of interventions to promote Diversity & Inclusion, with the publication of a company policy dedicated to these issues in 2022 and the definition of a structured training course that will involve almost the entire company workforce by 2025. The goal of closing the gender pay gap by 2028 has also been confirmed.

The second edition of the Sustainability Report also contains organisational innovations such as the direct involvement of stakeholders in the materiality analysis and the creation of a dedicated team headed by an ESG Manager.

www.bormiolipharma.com